Free Trial

MarketBeat Instant News Alerts

Hesai Group logo with Auto/Tires/Trucks background

Hesai Group (NASDAQ:HSAI) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

The Goldman Sachs Group boosted their price objective on shares of Hesai Group from $26.30 to $36.00 and gave the stock a "buy" rating in a research report on Monday.

NASDAQ:HSAI
Read Hesai Group (NASDAQ:HSAI) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
Kosmos Energy logo with Energy background

Kosmos Energy (NYSE:KOS) Earns Neutral Rating from The Goldman Sachs Group

The Goldman Sachs Group restated a "neutral" rating and set a $2.00 price objective (down previously from $3.00) on shares of Kosmos Energy in a research report on Monday.

NYSE:KOS
Read Kosmos Energy (NYSE:KOS) Earns Neutral Rating from The Goldman Sachs Group
Lumentum logo with Computer and Technology background

Lumentum (NASDAQ:LITE) Stock Price Expected to Rise, Rosenblatt Securities Analyst Says

Rosenblatt Securities raised their price objective on shares of Lumentum from $150.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday.

NASDAQ:LITE
Read Lumentum (NASDAQ:LITE) Stock Price Expected to Rise, Rosenblatt Securities Analyst Says
Humana logo with Medical background

Humana (NYSE:HUM) Now Covered by Evercore ISI

Evercore ISI assumed coverage on Humana in a research report on Monday. They set an "in-line" rating and a $295.00 price objective for the company.

NYSE:HUM
Read Humana (NYSE:HUM) Now Covered by Evercore ISI
Brinker International logo with Retail/Wholesale background

Wells Fargo & Company Upgrades Brinker International (NYSE:EAT) to "Overweight"

Wells Fargo & Company raised shares of Brinker International from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $165.00 to $175.00 in a research note on Monday.

NYSE:EAT
Read Wells Fargo & Company Upgrades Brinker International (NYSE:EAT) to "Overweight"
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Outperform at BMO Capital Markets

BMO Capital Markets upgraded Sarepta Therapeutics from a "market perform" rating to an "outperform" rating and set a $50.00 target price for the company in a research report on Monday.

NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Outperform at BMO Capital Markets

Trending News

All MarketBeat Instant News Alerts

FactSet Research Systems logo with Business Services background

FactSet Research Systems (NYSE:FDS) Upgraded to Buy at UBS Group

NYSE:FDS
Read FactSet Research Systems (NYSE:FDS) Upgraded to Buy at UBS Group
Ryder System logo with Transportation background

Citigroup Initiates Coverage on Ryder System (NYSE:R)

NYSE:R
Read Citigroup Initiates Coverage on Ryder System (NYSE:R)
Tesla logo with Auto/Tires/Trucks background

Tesla (NASDAQ:TSLA) Stock Price Expected to Rise, Piper Sandler Analyst Says

NASDAQ:TSLA
Read Tesla (NASDAQ:TSLA) Stock Price Expected to Rise, Piper Sandler Analyst Says
Plexus logo with Computer and Technology background

Plexus (NASDAQ:PLXS) Stock Price Expected to Rise, Benchmark Analyst Says

NASDAQ:PLXS
Read Plexus (NASDAQ:PLXS) Stock Price Expected to Rise, Benchmark Analyst Says
Guardant Health logo with Medical background

Guardant Health (NASDAQ:GH) Given Buy Rating at BTIG Research

NASDAQ:GH
Read Guardant Health (NASDAQ:GH) Given Buy Rating at BTIG Research
Cytokinetics logo with Medical background

Cytokinetics' (CYTK) "Buy" Rating Reiterated at HC Wainwright

NASDAQ:CYTK
Read Cytokinetics' (CYTK) "Buy" Rating Reiterated at HC Wainwright
Halozyme Therapeutics logo with Medical background

Halozyme Therapeutics (NASDAQ:HALO) Stock Price Expected to Rise, HC Wainwright Analyst Says

NASDAQ:HALO
Read Halozyme Therapeutics (NASDAQ:HALO) Stock Price Expected to Rise, HC Wainwright Analyst Says
NioCorp Developments logo with Basic Materials background

HC Wainwright Increases NioCorp Developments (NASDAQ:NB) Price Target to $8.25

NASDAQ:NB
Read HC Wainwright Increases NioCorp Developments (NASDAQ:NB) Price Target to $8.25
Neurocrine Biosciences logo with Medical background

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $170.00 at Needham & Company LLC

NASDAQ:NBIX
Read Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $170.00 at Needham & Company LLC
Lennar logo with Construction background

JPMorgan Chase & Co. Cuts Lennar (NYSE:LEN) Price Target to $92.00

NYSE:LEN
Read JPMorgan Chase & Co. Cuts Lennar (NYSE:LEN) Price Target to $92.00
Atossa Genetics logo with Medical background

Ascendiant Capital Markets Issues Positive Forecast for Atossa Genetics (NASDAQ:ATOS) Stock Price

NASDAQ:ATOS
Read Ascendiant Capital Markets Issues Positive Forecast for Atossa Genetics (NASDAQ:ATOS) Stock Price
Lattice Semiconductor logo with Computer and Technology background

Lattice Semiconductor (NASDAQ:LSCC) Price Target Raised to $80.00

NASDAQ:LSCC
Read Lattice Semiconductor (NASDAQ:LSCC) Price Target Raised to $80.00
Southern logo with Utilities background

Southern Company (The) $SO Position Raised by AGP Franklin LLC

NYSE:SO
Read Southern Company (The) $SO Position Raised by AGP Franklin LLC
Salesforce logo with Computer and Technology background

Golden State Equity Partners Increases Stock Holdings in Salesforce Inc. $CRM

NYSE:CRM
Read Golden State Equity Partners Increases Stock Holdings in Salesforce Inc. $CRM
Procter & Gamble logo with Consumer Staples background

Golden State Equity Partners Sells 2,388 Shares of Procter & Gamble Company (The) $PG

NYSE:PG
Read Golden State Equity Partners Sells 2,388 Shares of Procter & Gamble Company (The) $PG
Thermo Fisher Scientific logo with Medical background

Thermo Fisher Scientific Inc. $TMO Shares Bought by Golden State Equity Partners

NYSE:TMO
Read Thermo Fisher Scientific Inc. $TMO Shares Bought by Golden State Equity Partners
Novo Nordisk A/S logo with Medical background

Golden State Equity Partners Acquires 11,983 Shares of Novo Nordisk A/S $NVO

NYSE:NVO
Read Golden State Equity Partners Acquires 11,983 Shares of Novo Nordisk A/S $NVO
Abbott Laboratories logo with Medical background

Golden State Equity Partners Acquires 3,496 Shares of Abbott Laboratories $ABT

NYSE:ABT
Read Golden State Equity Partners Acquires 3,496 Shares of Abbott Laboratories $ABT
CrowdStrike logo with Computer and Technology background

Golden State Equity Partners Buys 661 Shares of CrowdStrike $CRWD

NASDAQ:CRWD
Read Golden State Equity Partners Buys 661 Shares of CrowdStrike $CRWD
Realty Income logo with Finance background

Golden State Equity Partners Has $1.31 Million Stock Holdings in Realty Income Corporation $O

NYSE:O
Read Golden State Equity Partners Has $1.31 Million Stock Holdings in Realty Income Corporation $O
KKR & Co. Inc. logo with Finance background

Golden State Equity Partners Raises Stake in KKR & Co. Inc. $KKR

NYSE:KKR
Read Golden State Equity Partners Raises Stake in KKR & Co. Inc. $KKR
Caterpillar logo with Industrials background

Golden State Equity Partners Lowers Stock Holdings in Caterpillar Inc. $CAT

NYSE:CAT
Read Golden State Equity Partners Lowers Stock Holdings in Caterpillar Inc. $CAT
CocaCola logo with Consumer Staples background

Golden State Equity Partners Has $1.65 Million Stock Position in CocaCola Company (The) $KO

NYSE:KO
Read Golden State Equity Partners Has $1.65 Million Stock Position in CocaCola Company (The) $KO
BlackRock logo with Finance background

Golden State Equity Partners Has $1.80 Million Stock Holdings in BlackRock $BLK

NYSE:BLK
Read Golden State Equity Partners Has $1.80 Million Stock Holdings in BlackRock $BLK